Laboratory preparedness for SARS-CoV-2 testing in India
Nivedita Gupta(Indian Council of Medical Research), Priya Abraham(ICMR-National Institute of Virology), Babita Fageria(Government Medical College), Lalit Dar(All India Institute of Medical Sciences), Pragya D. Yadav, G.B. Shantala(Bangalore Medical College and Research Institute), Gajanan Sapkal(ICMR-National Institute of Virology), Gitika Rajbongshi(Gauhati Medical College and Hospital), Sivasubramanian Srinivasan(King Institute of Preventive Medicine and Research), K. Nagamani(Gandhi Medical College & Hospital), Anu Nagar(Government of India), Jayanthi Shastri(Kasturba Hospital), Varsha Potdar(ICMR-National Institute of Virology), Manohar Lal Choudhary(ICMR-National Institute of Virology), R. Ambica(Bangalore Medical College and Research Institute), Pakalpati Sunita(Gandhi Medical College & Hospital), Jayaswamy Manjunatha(ICMR-National Institute of Virology), Jitendra Narayan(Government of India), Ira Praharaj(Indian Council of Medical Research), Manish Pathak(Kasturba Hospital), Sidhartha Giri(Indian Council of Medical Research), Shanta Dutta(National Institute of Research in Tuberculosis), AP Sugunan(ICMR-National Institute of Virology), Bharti Malhotra(SMS Medical College), Megha Brijwal(All India Institute of Medical Sciences), Harmanmeet Kaur(Government of India), Ashok Munivenkatappa(ICMR-National Institute of Virology), Amita Jain(King George's Medical University), Sharmila Raut(Government Medical College), Himanshu Sharma(SMS Medical College), Parul Jain(King George's Medical University), Mahendra Vegad(B.J. Medical College), Hasina Banu(National Institute of Cholera and Enteric Diseases), Anukumar Balakrishnan(ICMR-National Institute of Virology), Ajanta Sharma(Gauhati Medical College and Hospital), Raman R. Gangakhedkar(National Center for Disease Control), Aashish Choudhary(All India Institute of Medical Sciences), Krishnasamy Kaveri(King Institute of Preventive Medicine and Research), Neetu Vijay(Government of India), Disha Patel(B.J. Medical College), Neeraj Aggarwal(Indian Council of Medical Research)
Cited by 47
Related Papers
SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India
|Microorganisms|2021|658
Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events
|Nature Genetics|2015|489
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
|The Lancet|2021|361
Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India
|bioRxiv (Cold Spring Harbor Laboratory)|2021|268